Schafer Boeder

800 total citations
20 papers, 490 citations indexed

About

Schafer Boeder is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Schafer Boeder has authored 20 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Surgery and 7 papers in Genetics. Recurrent topics in Schafer Boeder's work include Diabetes Management and Research (16 papers), Diabetes and associated disorders (7 papers) and Diabetes Treatment and Management (7 papers). Schafer Boeder is often cited by papers focused on Diabetes Management and Research (16 papers), Diabetes and associated disorders (7 papers) and Diabetes Treatment and Management (7 papers). Schafer Boeder collaborates with scholars based in United States, Australia and China. Schafer Boeder's co-authors include Jeremy Pettus, Erin R. Giovannetti, Steven V. Edelman, Justin M. Gregory, Sara H. Duffus, Lauren M. LeStourgeon, Allison B. McCoy, James C. Slaughter, Sarah S. Jaser and Daniel J. Moore and has published in prestigious journals such as Nature Medicine, Diabetes Care and Diabetes.

In The Last Decade

Schafer Boeder

17 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Schafer Boeder United States 11 264 154 145 126 84 20 490
Rossella Tozzi Italy 12 229 0.9× 75 0.5× 68 0.5× 212 1.7× 395 4.7× 23 793
Eka Melson United Kingdom 11 201 0.8× 74 0.5× 72 0.5× 21 0.2× 121 1.4× 35 441
João Soares Felício Brazil 14 222 0.8× 73 0.5× 81 0.6× 44 0.3× 38 0.5× 37 484
Masamoto Torisu Japan 12 139 0.5× 61 0.4× 36 0.2× 36 0.3× 58 0.7× 25 360
Konstantinos Kakleas Greece 12 301 1.1× 120 0.8× 311 2.1× 20 0.2× 30 0.4× 27 561
Pei Chia Eng United Kingdom 12 203 0.8× 39 0.3× 21 0.1× 103 0.8× 38 0.5× 41 491
Michael Harris United States 13 136 0.5× 72 0.5× 31 0.2× 17 0.1× 47 0.6× 27 398
Elena Faleschini Italy 12 223 0.8× 111 0.7× 169 1.2× 49 0.4× 30 0.4× 38 405
Florencia Ceriani Uruguay 12 60 0.2× 44 0.3× 55 0.4× 26 0.2× 131 1.6× 23 371
Harald Kojzar Austria 12 478 1.8× 360 2.3× 287 2.0× 17 0.1× 94 1.1× 33 570

Countries citing papers authored by Schafer Boeder

Since Specialization
Citations

This map shows the geographic impact of Schafer Boeder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Schafer Boeder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Schafer Boeder more than expected).

Fields of papers citing papers by Schafer Boeder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Schafer Boeder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Schafer Boeder. The network helps show where Schafer Boeder may publish in the future.

Co-authorship network of co-authors of Schafer Boeder

This figure shows the co-authorship network connecting the top 25 collaborators of Schafer Boeder. A scholar is included among the top collaborators of Schafer Boeder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Schafer Boeder. Schafer Boeder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giovannetti, Erin R., Robert L. Thomas, Rabia Ali, et al.. (2025). Continuous Glucose Monitoring–Guided Insulin Infusion in Critically Ill Patients Promotes Safety, Improves Time Efficiency, and Enhances Provider Satisfaction. Endocrine Practice. 31(9). 1143–1149.
2.
3.
Thomas, Robert L., et al.. (2024). Continuous Glucose Monitoring Time Below Range Predicts Impaired Epinephrine Response to Hypoglycemia in Patients With Type 1 Diabetes. Diabetes Care. 47(5). e39–e41. 6 indexed citations
4.
Boeder, Schafer, Michael J. Davies, Janet B. McGill, et al.. (2024). Beta-Hydroxybutyrate Levels and Risk of Diabetic Ketoacidosis in Adults with Type 1 Diabetes Treated with Sotagliflozin. Diabetes Technology & Therapeutics. 26(9). 618–625. 10 indexed citations
5.
Ginsberg, Charles, Jesse C. Seegmiller, Volker Vallon, et al.. (2024). Acetazolamide Therapy and Kidney Function in Persons with Nonalbuminuric Diabetes Mellitus Type 1. Journal of the American Society of Nephrology. 36(3). 463–470. 3 indexed citations
6.
Boeder, Schafer, et al.. (2024). Combination SGLT2 Inhibitor and Glucagon Receptor Antagonist Therapy in Type 1 Diabetes: A Randomized Clinical Trial. Diabetes Care. 48(1). 52–60. 12 indexed citations
7.
Ciaraldi, Theodore P., Schafer Boeder, Sunder Mudaliar, et al.. (2023). Astaxanthin, a natural antioxidant, lowers cholesterol and markers of cardiovascular risk in individuals with prediabetes and dyslipidaemia. Diabetes Obesity and Metabolism. 25(7). 1985–1994. 22 indexed citations
8.
Boeder, Schafer, et al.. (2022). Accuracy and Glycemic Efficacy of Continuous Glucose Monitors in Critically Ill COVID-19 Patients: A Retrospective Study. Journal of Diabetes Science and Technology. 17(3). 642–648. 23 indexed citations
9.
Pettus, Jeremy, Schafer Boeder, Mark P. Christiansen, et al.. (2022). Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial. Nature Medicine. 28(10). 2092–2099. 39 indexed citations
10.
11.
Klein, Klara R., Schafer Boeder, Imogene Dunn, et al.. (2022). Impact of the hepatoselective glucokinase activator TTP399 on ketoacidosis during insulin withdrawal in people with type 1 diabetes. Diabetes Obesity and Metabolism. 24(8). 1439–1447. 7 indexed citations
12.
Boeder, Schafer, et al.. (2022). PSAT324 Altered Mental Status, Hypercalcemia, and Atrial Fibrillation Induced by Post-Parathyroidectomy Thyroiditis. Journal of the Endocrine Society. 6(Supplement_1). A823–A824. 1 indexed citations
13.
Boeder, Schafer, Justin M. Gregory, Erin R. Giovannetti, & Jeremy Pettus. (2021). SGLT2 Inhibition Increases Fasting Glucagon but Does Not Restore the Counterregulatory Hormone Response to Hypoglycemia in Participants With Type 1 Diabetes. Diabetes. 71(3). 511–519. 9 indexed citations
14.
15.
Edelman, Steven V., Tricia Santos Cavaiola, Schafer Boeder, & Jeremy Pettus. (2020). Utilizing continuous glucose monitoring in primary care practice: What the numbers mean. Primary care diabetes. 15(2). 199–207. 18 indexed citations
16.
Boeder, Schafer & Kristen Kulasa. (2020). Hospital care: improving outcomes in type 1 diabetes. Current Opinion in Endocrinology Diabetes and Obesity. 28(1). 14–20. 1 indexed citations
17.
Gregory, Justin M., James C. Slaughter, Sara H. Duffus, et al.. (2020). COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic’s Impact in Type 1 and Type 2 Diabetes. Diabetes Care. 44(2). 526–532. 189 indexed citations
18.
Boeder, Schafer & Steven V. Edelman. (2019). Sodium‐glucose co‐transporter inhibitors as adjunctive treatment to insulin in type 1 diabetes: A review of randomized controlled trials. Diabetes Obesity and Metabolism. 21(S2). 62–77. 32 indexed citations
19.
Pettus, Jeremy, Dominic N. Reeds, Tricia Santos Cavaiola, et al.. (2017). Effect of a glucagon receptor antibody (REMD‐477) in type 1 diabetes: A randomized controlled trial. Diabetes Obesity and Metabolism. 20(5). 1302–1305. 50 indexed citations
20.
Donovan, Lucas M., Schafer Boeder, Atul Malhotra, & Sanjay R. Patel. (2015). New developments in the use of positive airway pressure for obstructive sleep apnea.. eScholarship (California Digital Library). 7(8). 1323–42. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rossella Tozzi Breakdown of academic impact, for papers by Eka Melson Breakdown of academic impact, for papers by João Soares Felício Breakdown of academic impact, for papers by Masamoto Torisu Breakdown of academic impact, for papers by Konstantinos Kakleas Breakdown of academic impact, for papers by Pei Chia Eng Breakdown of academic impact, for papers by Michael Harris Breakdown of academic impact, for papers by Elena Faleschini Breakdown of academic impact, for papers by Florencia Ceriani Breakdown of academic impact, for papers by Harald Kojzar
Rankless by CCL
2026